量研学術機関リポジトリ「QST-Repository」は、国立研究開発法人 量子科学技術研究開発機構に所属する職員等が生み出した学術成果（学会誌発表論文、学会発表、研究開発報告書、特許等）を集積しインターネット上で広く公開するサービスです。 Welcome to QST-Repository where we accumulates and discloses the academic research results(Journal Publications, Conference presentation, Research and Development Report, Patent, etc.) of the members of National Institutes for Quantum Science and Technology.
Thank you very much for using our website. On the 11th of March 2019, this site was moved from our own network server to the JAIRO Cloud network server. If you previously bookmarked this site, that bookmark will no longer work. We would be grateful if you could bookmark the website again. Thank you very much for your understanding and cooperation.
In-vivo Imaging of Neuronal Differentiation and Function of Intracranially Implanted Induced Pluripotent Stem Cells (iPSCs) Using A Designer Receptor Exclusively Activated by A Designer Drug (DREADD)
利用統計を見る
Induced pluripotent stem cells (iPSCs) provide a promising resource for cell replacement therapy in neurological diseases. In the present study, we have applied a designer receptor exclusively activated by a designer drug (DREADD) derived from human M4 muscarinic acetylcholine receptor (hM4D) and its synthetic ligand to in-vivo visualization of neuronal differentiation and function of iPSC-derived grafts implanted into the brain. We successfully captured expression of hM4D driven by neuron-specific Thy-1 promoter in newly-developed hM4D transgenic (hM4D Tg) mice with a 11C-labeled positron emission tomography (PET) ligand for hM4D. We also established iPSCs from a hM4D Tg mouse (hM4D-iPSC), and visualized time course of neuronal differentiation of grafts generated from these iPSCs in the living wild-type mouse brain by longitudinal PET imaging of hM4D with its specific radioligand. Quantitative assessment for cerebral blood flow using arterial spin labeling (ASL) MRI indicated suppression of neuronal activity by clozapine-N-oxide (CNO), an exclusive activator of hM4D, in hM4D Tg but not wild-type mice, in consistency with attenuation of locomotion behaviors. Furthermore, we found CNO-induced reduction of cerebral blood flow in areas associated with implantation of hM4D-iPSC-derived grafts by ASL-MRI of recipient mice. Our results support the utility of hM4D in combination with PET and ASL-MRI for in-vivo longitudinal monitoring of neuronal differentiation and functional manipulation of iPSC-derived implants in the brain. Since this technology is potentially applicable to humans, it would accelerate translational research and development of cell replacement therapy towards clinical trials.
In-vivo Imaging of Neuronal Differentiation and Function of Intracranially Implanted Induced Pluripotent Stem Cells (iPSCs) Using A Designer Receptor Exclusively Activated by A Designer Drug (DREADD)
